| Publications |
| |
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Sandborn WJ, Feagan BG, Fedorak RN, Scherl E, Fleisher MR, Katz S, Johanns J, Blank M, Rutgeerts P; Ustekinumab Crohn's Disease Study Group
Gastroenterology. 2008 Oct;135(4):1130-41 |
| |
Warman JI, Korelitz BI, Fleisher MR, Janardhanam R. Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis. J Clin Gastroenterol. 2003 Sep;37(3):220-5. |
| |
Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol. 2003 Aug;98(8):1821-6. |
| |
Fleisher MR, Rubin SD, Levine AE. The Myriad Manifestations of Crohn's Disease Responsive to Infliximab.
Therapeutic Options for Crohn's and Colitis: A Case-Based Approach. 2001 November |
| |
Fleisher MR, Hopkins, K. Infliximab in the Treatment of Crohn's Disease Complicated by Granuloma Annulare. Therapeutic Options for Crohn's and Colitis: A Case-Based Approach. 2001 September |
| |
Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol. 1999 Nov;94(11):3248-53. |
| |
Zlatanic J, Fleisher M, Sasson M, Kim P, Korelitz BI. Crohn's disease and acute leukocytoclastic vasculitis of skin. Am J Gastroenterol. 1996 Nov;91(11):2410-3. Review. |
| |
Fleisher MR Lending a hand. Nursing. 1994 Jul;24(7):32T |
| |
Fleisher MR. A piece of my mind. Hands on. JAMA. 1994 Mar 2;271(9):642. |
| |
|
| Presentations |
| |
A Multicenter, Randomized Phase 2a Study of Human Monoclonal Antibody to IL-12/23p40 (CNTO 1275) in Patients With Moderately to Severe Active Crohn’s Disease Plenary Session, DDW 2007 |
| |
Safety of Infliximab in IBD Patients With Previously Treated Neoplasms Poster Presentation DDW 2003 |
| |
Steroids Versus Infliximab: Efficacy and Swiftness of Induction to Remission Poster Presentation DDW 2003 |
| |
Infliximab: Is it a 5-ASA and Antibiotics Sparing Drug in Crohn’s Disease? Poster Presentation DDW 2003 |
| |
Infliximab in the Treatment of IBD-Associated Psoriasis and Psoriasis-Associated IBD Poster Presentation ACG 2002 |
| |
Collagenous Colitis: Experiences of a Large Community-Based Practice Poster Presentation ACG 2002 |
| |
Successful Treatment of IBD-Associated Pyoderma Gangrenosum with Infliximab Poster Presentation DDW 2002 |
| |
Antinuclear Antibody and Rheumatoid Factor Expression in IBD Patients During Severe Presentations Poster Presentation, DDW 2002 |
| |
Infliximab in the Treatment of Steroid Refractory Erythema Nodosum of IBD Poster Presentation DDW 2002 |
| |
A Continuum of the Aspiration Technique in Biliary Type 3 Sphincter of Oddi Manometry Patients and the Incidence of Pancreatitis Poster Presentation DDW 2002 |
| |
Infliximab in the Treatment of Crohn's Disease Complicated by Granuloma Annulare Poster Presentation, AAD National Conference 2001 |
| |
REMICADE® (Infliximab) in the Management of Pyoderma Gangrenosum Poster Presentation, AAD National Conference 2001 |
| |
Infliximab in the Treatment of Steroid-Naïve Ulcerative Colitis. Poster Presentation, ACG National Conference 2001 |
| |
Infliximab in the Treatment of Crohn’s Disease: Is It a Steroid Sparing Agent or a Steroid Replacing Agent? Poster Presentation, ACG National Conference 2001 |
| |
A Case Report: Infliximab in the Treatment of Bechet’s Syndrome Poster Presentation, ACG National Conference 2001 |
| |
Remicade in the Treatment of Refractory Extraintestinal Manifestations of Crohn’s Disease Poster Presentation, DDW 2001 |
| |
Malignant Neoplasms Subsequent to Treatment of Inflammatory Bowel Disease with 6 – Mercaptopurine Plenary Session Presentation ACG National Conference 1996 |
| |
Intravenous ACTH versus Hydrocortisone in the Treatment of Hospitalized Patients with Crohn’s Disease Plenary Session Presentation ACG National Conference 1995 |
| |
Hypokalemia Due to Intravenous Hydrocortisone versus ACTH in the Treatment of Hospitalized Patients with Crohn’s Disease Poster Presentation ACG National Conference 1995 |
